A volunteer participates in the vaccine trial in Oxford, England on July 7. In research published on Monday in the journal Lancet, scientists said that they found their experimental Covid-19 vaccine produced a dual immune response in people aged 18 to 55. Photo: University of Oxford via AP
What happens next, as coronavirus vaccine trials move to a new phase?
- Teams from China, Britain, the US and Germany have shown their potential products are safe but there’s still a long way to go
- Broad testing across a diverse range – including elderly and less healthy subjects – is crucial to assessing how a vaccine might work on a population
Topic |
Coronavirus pandemic
A volunteer participates in the vaccine trial in Oxford, England on July 7. In research published on Monday in the journal Lancet, scientists said that they found their experimental Covid-19 vaccine produced a dual immune response in people aged 18 to 55. Photo: University of Oxford via AP